Molecular biologic substaging of stage I lung cancer according to gender and histology

Annals of Thoracic Surgery

Volumn 69, Issue 3, 2000, Pages 882-886

  D'Amico, Thomas A ^a   Aloia, Thomas A ^a   Moore, Mary Beth H ^a   Herndon II, James E ^a   Brooks, Kelli R ^a   Lau, Christine L ^a   Harpole Jr, David H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; RETINOBLASTOMA PROTEIN; SIALIC ACID DERIVATIVE; TUMOR MARKER;

ARTICLE; CANCER MODEL; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MULTIVARIATE ANALYSIS; ONCOGENE NEU; PRIORITY JOURNAL; PROTO ONCOGENE; REGRESSION ANALYSIS; SEX DIFFERENCE;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENETIC MARKERS; HUMANS; LUNG NEOPLASMS; MALE; MOLECULAR BIOLOGY; NEOPLASM STAGING; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 0034027040     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01522-2     Document Type: Article

References (17)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics, 1999. CA Cancer J Clin. 49:1999;8-31.
2. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest. 111:1997;1710-1717.
3. Lau CL, D'Amico TA, Harpole DH. Staging and prognosis: clinical and molecular prognostic factors and models for non-small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD, eds. Lung cancer: principles and practice, 2nd ed. Philadelphia: Lippincott, Williams and Wilkins, 1999 (in press).
4. D'Amico T.A., Massey M., Herndon J.E., et al. A biological risk model for stage I lung cancer immunohistochemical analysis of 408 patients with use of ten molecular markers . J Thorac Cardiovasc Surg. 117:1999;736-743.
5. Harpole D.H. Jr, Herndon J.E. II, Young W.G., Wolfe W.G., Sabiston D.C. Jr. Stage I non-small cell lung cancer a multivariate analysis of treatment methods and patterns . Cancer. 76:1995;787-796.
6. Harpole D.H. Jr, Herndon J.E. II, Wolfe W.G., Iglehart J.D., Marks J.R. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res. 55:1995;51-56.
7. Harpole D.H. Jr, Richards W.G., Herndon J.E. II, Sugarbaker D.J. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg. 61:1996;1470-1476.
8. Strauss G.M., Kwiatkowski D.J., Harpole D.H., Lynch T.J., Skarin A.T., Sugarbaker D.J. Molecular and pathologic markers in stage I non-small cell carcinoma of the lung. J Clin Oncol. 13:1995;1265-1279.
9. Kwiatkowski D.J., Harpole D.H. Jr, Godleski J., et al. Molecular pathologic substaging in 244 stage I non-small cell lung cancer patients clinical implications . J Clin Oncol. 16:1998;2468-2477.
10. Pastorino U., Andreola S., Tagliabue E., et al. Immunocytochemical markers in stage I lung cancer relevance to prognosis . J Clin Oncol. 15:1997;2858-2865.
11. Andrews J.L., Bloom S., Balogh, Beamis J.F. Lung cancer in women. Cancer. 55:1985;2894-2898.
12. Canver C.C., Memoli V.A., Vanderveer P.L., Dingivan C.A., Mentzer R.M. Sex hormone receptors in non-small cell lung cancer in human beings. J Thorac Cardiovasc Surg. 108:1994;153-157.
13. Baldini E.H., Strauss G.M. Women and lung cancer waiting to exhale . Chest. 112:(Suppl):1997;229-234s.
14. Ouellette D., Desbiens G., Emond C., Beauchamp G. Lung cancer in women compared to men stage, treatment, and survival . Ann Thorac Surg. 66:1998;1140-1143.
15. Sekine I., Nishikawa Y., Yokose T., Nagai K., Suzuki K., Kodama T. Young lung cancer patients in Japan different characteristics between the sexes . Ann Thorac Surg. 67:1999;1451-1455.
16. Barbone F., Bovenzi M., Cavallieri F., Stanta G. Cigarette smoking and histologic subtype of lung cancer in men. Chest. 112:1997;1474-1479.
17. Fujisawa T., Iizasa T., Saitoh Y., et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small cell lung carcinomas. J Clin Oncol. 17:1999;2086-2091.